Fulminant Clostridium difficile colitis in a post-liver transplant patient

Dig Dis Sci. 2010 Sep;55(9):2459-62. doi: 10.1007/s10620-010-1318-y. Epub 2010 Jul 16.

Authors

Maximilian Lee¹, Andrew A Shelton, Waldo L Concepcion, Clark A Bonham, Tami J Daugherty

Affiliation

¹ Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University Medical Center, 300 Pasteur Dr., Always Bldg. M211, Stanford, CA 94305-5187, USA. maxlee@stanford.edu

PMID: 20635145
DOI: 10.1007/s10620-010-1318-y

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / adverse effects
Bacterial Proteins / genetics
Bacterial Toxins / genetics
Clostridioides difficile / genetics
Clostridioides difficile / isolation & purification*
Colectomy
Colon / diagnostic imaging
Colon / microbiology*
Colon / pathology
Colon / surgery
Compartment Syndromes / microbiology
Enterocolitis, Pseudomembranous / diagnostic imaging
Enterocolitis, Pseudomembranous / microbiology*
Enterocolitis, Pseudomembranous / pathology
Enterocolitis, Pseudomembranous / surgery
Feces / microbiology
Female
Humans
Ileostomy
Immunosuppressive Agents / adverse effects
Liver Transplantation / adverse effects*
Multiple Organ Failure / microbiology
Polymerase Chain Reaction
Radiography, Abdominal
Treatment Outcome

Substances

Anti-Bacterial Agents
Bacterial Proteins
Bacterial Toxins
Immunosuppressive Agents
toxB protein, Clostridium difficile